Is the protection resulting from natural infection better than the protection resulting from vaccination?
One report from Israel suggests natural infection is superior medrxiv.org/content/10.110…, and UK study and a Kentucky study ndm.ox.ac.uk/files/coronavi…
cdc.gov/mmwr/volumes/7…
appear to reach different conclusions.
For medical records surveys it is difficult to control for under-reporting asymptomatic infections, behavior, and times at which subjects became eligible for vaccination.A strong point of the UK study is that it also involved actual households PCR tests to measure infections.
It is true that natural infection provides substantial protection from reinfection. And it is also true that vaccination provides substantial protection.
Comparing the two; Immune responses induced by natural infection are weak in about 10% of people after 8-months; having been infected does not ensure the presence of good humoral and T cell responses. Responses induced by natural infection are in general of lower magnitude.
However, currently vaccines only induce responses against spike. T cells against non-spike antigens induced by infection might make a substantial difference. And the localized response resulting from infection might more effective than systemic response resulting from vaccination
Comparing protection from infection or vaccination, the question is not “should I get COVID or be vaccinated”? COVID is associated with high disease burden, risk of death and long-lasting health issues (long COVID), in contrast with the excellent safety profile of vaccination.
The question is "should I get vaccinated even if I previously had covid?" People that were infected and then vaccinated develop a powerful immune response, called “hybrid immunity”, which exceeds what is seen with either natural infection or vaccination.
A higher immune response would be expected to overcome decreased capacity of antibodies to neutralize variants. Studies have shown that even a single shot of RNA vaccine is capable of inducing strong responses in previously infected individuals.
Break-trough infections, albeit associated with lower disease severity, can spread infection to unprotected people. Bottom line, vaccination of previously infected individuals provides strong benefit to the individual, and to others as well.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Alessandro Sette

Alessandro Sette Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @SetteLab

1 Jul
1/8 The latest version of our paper showing the limited impact of the SARS-CoV-2 variants on T cell reactivity is out today in @CellRepMed @aetarke @Alba_Grifoni @profshanecrotty @Dani6020 @ljiresearch cell.com/cell-reports-m…
2/8 The original study was available on march 01 2021 in biorxiv biorxiv.org/content/10.110….
3/8 Since the BioRxiv preprint, we have strengthened our conclusions by nearly tripling the # of donors tested and adding an additional cohort of unexposed donors. What do we show?
Read 8 tweets
21 May
Our latest metanalysis of SARS-CoV-2T cell epitopes combines results from 25 different studies. 1400 epitopes for thus far defined from the worldwide scientific community studying CD4 and/orCD8 T cells . cell.com/cell-host-micr…
This amazing diversity is even more striking considering that the epitopes presented by many HLA alleles are relatively understated, which means the actual numbers are likely to be much higher.
The collective knowledge zeros in on immunodominant regions, that can be used to monitor responses and also as potential vaccine components
Read 5 tweets
2 Mar
Check out the latest experimental work from our group.biorxiv.org/content/10.110…; Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.@atarke @Alba_Grifoni @profshanecrotty @Dani6020.
1-CD4 and CD8 T cells induced by the ancestral reference sequence recognize the four common SARS-CoV2 variants B.1.1.7, B.1.153, P.1. and CAL.20C.
2-We think this is really good news. This is true for both COVID survivors and people who received the Moderna and Pfizer vaccines.
Read 9 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(